Correlation Between Red Branch and Dianthus Therapeutics
Can any of the company-specific risk be diversified away by investing in both Red Branch and Dianthus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Red Branch and Dianthus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Red Branch Technologies and Dianthus Therapeutics, you can compare the effects of market volatilities on Red Branch and Dianthus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Red Branch with a short position of Dianthus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Red Branch and Dianthus Therapeutics.
Diversification Opportunities for Red Branch and Dianthus Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Red and Dianthus is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Red Branch Technologies and Dianthus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dianthus Therapeutics and Red Branch is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Red Branch Technologies are associated (or correlated) with Dianthus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dianthus Therapeutics has no effect on the direction of Red Branch i.e., Red Branch and Dianthus Therapeutics go up and down completely randomly.
Pair Corralation between Red Branch and Dianthus Therapeutics
If you would invest 0.01 in Red Branch Technologies on September 14, 2024 and sell it today you would earn a total of 0.00 from holding Red Branch Technologies or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Red Branch Technologies vs. Dianthus Therapeutics
Performance |
Timeline |
Red Branch Technologies |
Dianthus Therapeutics |
Red Branch and Dianthus Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Red Branch and Dianthus Therapeutics
The main advantage of trading using opposite Red Branch and Dianthus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Red Branch position performs unexpectedly, Dianthus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dianthus Therapeutics will offset losses from the drop in Dianthus Therapeutics' long position.Red Branch vs. Dave Warrants | Red Branch vs. Swvl Holdings Corp | Red Branch vs. Guardforce AI Co | Red Branch vs. Thayer Ventures Acquisition |
Dianthus Therapeutics vs. Puma Biotechnology | Dianthus Therapeutics vs. Iovance Biotherapeutics | Dianthus Therapeutics vs. Day One Biopharmaceuticals | Dianthus Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |